These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7913586)

  • 1. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results.
    Sanders RD; Keshavan MS; Schooler NR
    Am J Psychiatry; 1994 Aug; 151(8):1231-3. PubMed ID: 7913586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.
    Gupta S; Andreasen NC; Arndt S; Flaum M; Schultz SK; Hubbard WC; Smith M
    Am J Psychiatry; 1995 Feb; 152(2):191-6. PubMed ID: 7840351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological abnormalities in schizophrenic patients and their siblings.
    Ismail B; Cantor-Graae E; McNeil TF
    Am J Psychiatry; 1998 Jan; 155(1):84-9. PubMed ID: 9433343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal neurologic maturation in adolescents with early-onset schizophrenia.
    Karp BI; Garvey M; Jacobsen LK; Frazier JA; Hamburger SD; Bedwell JS; Rapoport JL
    Am J Psychiatry; 2001 Jan; 158(1):118-22. PubMed ID: 11136643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic comorbidities in schizophrenia.
    Nasrallah HA
    J Clin Psychiatry; 2005; 66 Suppl 6():34-46. PubMed ID: 16107182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses.
    Keshavan MS; Sanders RD; Sweeney JA; Diwadkar VA; Goldstein G; Pettegrew JW; Schooler NR
    Am J Psychiatry; 2003 Jul; 160(7):1298-304. PubMed ID: 12832245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological soft signs in first-episode schizophrenia: a follow-up study.
    Bachmann S; Bottmer C; Schröder J
    Am J Psychiatry; 2005 Dec; 162(12):2337-43. PubMed ID: 16330599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of neuropsychological performance by neurological signs in schizophrenia.
    Arango C; Bartko JJ; Gold JM; Buchanan RW
    Am J Psychiatry; 1999 Sep; 156(9):1349-57. PubMed ID: 10484944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2-year stability of neurological soft signs after a first episode of non-affective psychosis.
    Boks MP; Selten JP; Leask S; Van den Bosch RJ
    Eur Psychiatry; 2006 Jul; 21(5):288-90. PubMed ID: 16380235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia.
    Sanders RD; Allen DN; D Forman S; Tarpey T; Keshavan MS; Goldstein G
    Psychiatry Res; 2005 Jan; 133(1):65-71. PubMed ID: 15698678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological impairment and its neurological correlates in adult offspring with heightened risk for schizophrenia and affective psychosis.
    Schubert EW; McNeil TF
    Am J Psychiatry; 2005 Apr; 162(4):758-66. PubMed ID: 15800150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological soft signs in obsessive-compulsive disorder: the effect of co-morbid psychosis and evidence for familiality.
    Peng ZW; Xu T; Miao GD; He QH; Zhao Q; Dazzan P; Chan RC
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):200-5. PubMed ID: 22735396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients.
    Janno S; Holi M; Tuisku K; Wahlbeck K
    Am J Psychiatry; 2004 Jan; 161(1):160-3. PubMed ID: 14702266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
    Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
    Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.
    Peralta V; Moreno-Izco L; Sanchez-Torres A; García de Jalón E; Campos MS; Cuesta MJ
    Schizophr Bull; 2014 Jan; 40(1):214-24. PubMed ID: 23256987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological soft signs in adolescents with first episode psychosis.
    Zabala A; Robles O; Parellada M; Moreno DM; Ruiz-Sancho A; Burdalo M; Medina O; Arango C
    Eur Psychiatry; 2006 Jul; 21(5):283-7. PubMed ID: 16360308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of soft neurological signs in positive and negative subtype of schizophrenia.
    Cvetić T; Vuković O; Britvić D; Ivković M; Dukić-Dejanović S; Lecić-Tosevski D
    Psychiatr Danub; 2009 Jun; 21(2):174-8. PubMed ID: 19556945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for spontaneous dyskinesia in schizophrenia.
    Fenton WS; Wyatt RJ; McGlashan TH
    Arch Gen Psychiatry; 1994 Aug; 51(8):643-50. PubMed ID: 8042913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.